Alpine Immune Sciences (ALPN) Competitor Comparison
We are evaluating the key criteria listed to compare Alpine Immune Sciences (ALPN) against its competitors in the Biotechnology industry.
Market Capitalization
72 / 368Gross Profits
188 / 278Total Revenue
144 / 300EBITDA
159 / 337Free Cashflow
195 / 352Quick Ratio
235 / 357Earnings per Share
99 / 359Dividend yield
0 / 6Total Cash
160 / 358Performance 3 years
14 / 368Performance 5 years
8 / 368Performance 10 years
106 / 368Linearity 3 years
353 / 368Linearity 5 years
341 / 368Linearity 10 years
84 / 368Total Rank
100 / 368Dividend Rank
344 / 368Valuation Rank
168 / 368Piotroski Rank
71 / 368Muliplier Rank
262 / 368Earnings per Share - ALPN ranking 99 / 359
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.